A citation-based method for searching scientific literature

Luan Nguyen, John W M Martens, Arne Van Hoeck, Edwin Cuppen. Nat Commun 2020
Times Cited: 133

Neha Chopra, Holly Tovey, Alex Pearson, Ros Cutts, Christy Toms, Paula Proszek, Michael Hubank, Mitch Dowsett, Andrew Dodson, Frances Daley, Divya Kriplani, Heidi Gevensleben, Helen Ruth Davies, Andrea Degasperi, Rebecca Roylance, Stephen Chan, Andrew Tutt, Anthony Skene, Abigail Evans, Judith M Bliss, Serena Nik-Zainal, Nicholas C Turner. Nat Commun 2020
Times Cited: 101

List of shared articles

Times cited

Therapeutic and prognostic insights from the analysis of cancer mutational signatures.
Samuel W Brady, Alexander M Gout, Jinghui Zhang. Trends Genet 2022

The future potential of genome-wide mutational profiles in HRD detection in breast cancer.
Benedetta Pellegrino, Chiara Tommasi, Cinzia Solinas, Nicoletta Campanini, Enrico Maria Silini, Antonino Musolino. Expert Rev Mol Diagn 2022

A decade of RAD51C and RAD51D germline variants in cancer.
Jacopo Boni, Aida Idani, Carla Roca, Lidia Feliubadaló, Eva Tomiak, Evan Weber, William D Foulkes, Alexandre Orthwein, Zaki El Haffaf, Conxi Lazaro,[...]. Hum Mutat 2022

PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers.
Laetitia Collet, Julien Péron, Frédérique Penault-Llorca, Pascal Pujol, Jonathan Lopez, Gilles Freyer, Benoît You. Cancers (Basel) 2022

PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components.
Geraldine O'Sullivan Coyne, Chris Karlovich, Deborah Wilsker, Andrea Regier Voth, Ralph E Parchment, Alice P Chen, James H Doroshow. Onco Targets Ther 2022

An overview of mutational and copy number signatures in human cancer.
Christopher D Steele, Nischalan Pillay, Ludmil B Alexandrov. J Pathol 2022

Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
Benjamin D Leibowitz, Bonnie V Dougherty, Joshua S K Bell, Joshuah Kapilivsky, Jackson Michuda, Andrew J Sedgewick, Wesley A Munson, Tushar A Chandra, Jonathan R Dry, Nike Beaubier,[...]. BMC Cancer 2022

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.
Titia G Meijer, Luan Nguyen, Arne Van Hoeck, Anieta M Sieuwerts, Nicole S Verkaik, Marjolijn M Ladan, Kirsten Ruigrok-Ritstier, Carolien H M van Deurzen, Harmen J G van de Werken, Esther H Lips,[...]. Oncogene 2022

The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes.
Paula Štancl, Nancy Hamel, Keith M Sigel, William D Foulkes, Rosa Karlić, Paz Polak. Front Genet 2022

A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer.
Daodu Wang, Yifeng Shi, Hanyang Huang, Qijiong Zhao, Yongyue He, Wenzhi Su. Open Med (Wars) 2022

Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision Oncology.
Alexander M A van der Wiel, Lesley Schuitmaker, Ying Cong, Jan Theys, Arne Van Hoeck, Conchita Vens, Philippe Lambin, Ala Yaromina, Ludwig J Dubois. Cancers (Basel) 2022

Bioinformatics: From NGS Data to Biological Complexity in Variant Detection and Oncological Clinical Practice.
Serena Dotolo, Riziero Esposito Abate, Cristin Roma, Davide Guido, Alessia Preziosi, Beatrice Tropea, Fernando Palluzzi, Luciano Giacò, Nicola Normanno. Biomedicines 2022

Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation.
Marjolijn M Ladan, Dik C van Gent, Agnes Jager. Cancers (Basel) 2021

Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies.
Colin Stok, Yannick P Kok, Nathalie van den Tempel, Marcel A T M van Vugt. Nucleic Acids Res 2021